Cerevel Therapeutics Holdings, Inc. with ticker code (CERE) have now 9 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between 46 and 22 with the average target price sitting at $36.44. Given that the stocks previous close was at $31.96 this would imply there is now a potential upside of 14.0%. The 50 day moving average now sits at $27.23 and the 200 day MA is $29.23. The market capitalization for the company is 5.09B. The stock price is currently at: 32.46 USD
The potential market cap would be $5,804,402,400 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of – and a -31.87% return on assets.
